Clinical Research in Cardiology · 2020 · 152 citations · 16 references
MedicineCardiologyInternal MedicineAcute Care MedicineClinical CardiologyCritical Care CardiologyCardiac AssessmentCardiac BiomarkersCardiac Risk AssessmentCardiovascular AssessmentCardiovascular DiseaseCardiac Outcome AssessmentCardiovascular Disease ManagementCovid-19-associated Acute Respiratory Distress SyndromeIntracardiac EchocardiographyMyocardial Injury MarkersRight Ventricular Systolic FunctionTricuspid Regurgitation AssessmentTroponin Elevation
BACKGROUND: COVID-19 infection may cause severe respiratory distress and is associated with increased morbidity and mortality. Impaired cardiac function and/or pre-existing cardiovascular disease may be associated with poor prognosis. In the present study, we report a comprehensive cardiovascular characterization in the first consecutive collective of patients that was admitted and treated at the University Hospital of Tübingen, Germany. METHODS: 123 consecutive patients with COVID-19 were included. Routine blood sampling, transthoracic echocardiography and electrocardiography were performed at hospital admission. RESULTS: We found that impaired left-ventricular and right-ventricular function as well as tricuspid regurgitation > grade 1 were significantly associated with higher mortality. Furthermore, elevated levels of myocardial distress markers (troponin-I and NT pro-BNP) were associated with poor prognosis in this patient collective. CONCLUSION: Impaired cardiac function is associated with poor prognosis in COVID-19 positive patients. Consequently, treatment of these patients should include careful guideline-conform cardiovascular evaluation and treatment. Thus, formation of a competent Cardio-COVID-19 team may represent a major clinical measure to optimize therapy of cardiovascular patients during this pandemic.
16
Roberto M. Lang, Luigi P. Badano, Victor Mor‐Avi et al. · Journal of the American Society of Echocardiography · 2015 · 18K citations · Full text
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
Shaobo Shi, Mu Qin, Bo Shen et al. · JAMA Cardiology · 2020 · 4.5K citations · Full text
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Rick A. Nishimura, Catherine M Otto, Robert O. Bonow et al. · Circulation · 2014 · 2.6K citations
Medicine, Cardiology, Surgery +16
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
Riccardo M. Inciardi, Laura Lupi, G Zaccone et al. · JAMA Cardiology · 2020 · 1.9K citations · Full text